Krystal Biotech, Inc. (KRYS) Insider Ownership

Data spanning the past 90 days through February 19, 2026 reveals that Krystal Biotech's three principal insider shareholders consist of President And Ceo Krish S Krishnan (2.90Mn shares), President And R&D Suma Krishnan (2.90Mn shares), Director Daniel Janney (107.36K shares).

• A detailed ownership breakdown for Krystal Biotech is not available at this time.
• At February 19, 2026, insider ownership concentration at Krystal Biotech equals 19.86% of the company's equity base, encompassing roughly 6.01Mn shares from 30.24Mn total outstanding.
• Throughout the 90-day span concluding February 19, 2026, Krystal Biotech's insider stake decreased 1.61%, as collective insider positions declining from 6.10Mn shares to 6.01Mn shares.
• Throughout the 90-day period ending February 19, 2026, Chief Accounting Officer Kathryn Romano led insider buying activity at Krystal Biotech, acquiring 12.50K shares.
• As of February 19, 2026, President And R&D Suma Krishnan executed the most significant insider divestiture at Krystal Biotech, disposing of 55.00K shares over the last 90-day period.